{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:25:09Z","timestamp":1787117109333,"version":"build-2736575974"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We evaluated the safety of endoscopic procedures in cancer patients with neutropenia and\/or thrombocytopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected data on patients with neutropenia and\/or thrombocytopenia who underwent endoscopy between 2012 and 2022 at Roswell Park Comprehensive Cancer Center. Neutropenia was defined as absolute neutrophil count (ANC) &amp;lt;1500 cells\/\u00b5L, and thrombocytopenia was defined as platelet count &amp;lt;50 x 10\u00b3\/\u00b5L. The development of infectious AEs (fever within 3 days or positive blood cultures within 7 days following endoscopy) in neutropenic patients and bleeding AEs (new overt GI bleeding within 3 days following endoscopy) in thrombocytopenic patients were the primary outcome measures; 30-day mortality was a secondary outcome measure. Univariate and multivariate analyses by logistic regressions were used to evaluate for risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 234 patients who underwent 329 endoscopic procedures were identified. In neutropenic patients, 7.8% (8\/103) developed infectious AEs. In thrombocytopenic patients, 5.8% (12\/208) developed bleeding AEs. Use of granulocyte colony-stimulating factor (G-CSF) was associated with increased risk of infectious AEs (OR 5.79,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.02). The severity of neutropenia or thrombocytopenia and risk level of endoscopy were not associated with AEs. Multivariate analyses showed that poor performance status (PS) was the greatest risk factor for increased 30-day mortality (OR 4.69,\n                      <jats:italic>p<\/jats:italic>\n                      = &amp;lt;0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endoscopy in patients with neutropenia and thrombocytopenia is relatively safe and does not lead to significant morbidity. A careful risk-benefit analysis in cancer patients with poor PS should be conducted prior to endoscopy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgstr.2026.1890947","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:38:24Z","timestamp":1787114304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risks of GI endoscopy in cancer patients with neutropenia and thrombocytopenia"],"prefix":"10.3389","volume":"5","author":[{"given":"Clark","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University at Buffalo","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Cloutier","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobs School of Medicine and Biomedical Sciences","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Tamale","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobs School of Medicine and Biomedical Sciences","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debduti","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sisters of Charity Hospital","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University at Buffalo","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Robillard","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences","place":["Buffalo, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2019.07.033","article-title":"Asge review of adverse events in colonoscopy","volume":"90","author":"Kothari","year":"2019","journal-title":"Gastrointestinal Endoscopy"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2022.04.024","article-title":"Adverse events associated with egd and egd-related techniques","volume":"96","author":"Coelho-Prabhu","year":"2022","journal-title":"Gastrointestinal Endoscopy"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post ercp complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2014.08.008","article-title":"Antibiotic prophylaxis for gi endoscopy","volume":"81","author":"Khashab","year":"2015","journal-title":"Gastrointestinal Endoscopy"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing gi endoscopy","volume":"83","author":"Acosta","year":"2015","journal-title":"Gastrointestinal Endoscopy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2008.02.068","article-title":"Antibiotic prophylaxis for gi endoscopy","volume":"67","author":"Banerjee","year":"2008","journal-title":"Gastrointestinal Endoscopy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2018.12.004","article-title":"Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia","volume":"89","author":"Abh-Sbeih","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700281","article-title":"Safety of endoscopic interventions in patients with thrombocytopenia","volume":"80","author":"Krishna","year":"2014","journal-title":"Gastrointestinal Endoscopy"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07441-8","article-title":"Gastrointestinal endoscopy-associated infections: update on emerging issue","volume":"67","author":"Deb","year":"2022","journal-title":"Dig Dis Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2001.114422","article-title":"Prospective evaluation of complications in outpatient gi endoscopy: a survey among german gastroenterologists","volume":"53","author":"Sieg","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-022-09135-8","article-title":"Infectious events after endoscopic procedures in patients with neutropenia and hematologic diseases","volume":"36","author":"Shin","year":"2022","journal-title":"Surg Endoscopy"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0628","article-title":"Responsiveness to g-csf before leukopenia predicts defense to infection in high-dose chemotherapy recipients","volume":"104","author":"Straka","year":"2004","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis998","article-title":"Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy","volume":"56","author":"Nesher","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1890947\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:38:25Z","timestamp":1787114305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1890947\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":13,"alternative-id":["10.3389\/fgstr.2026.1890947"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2026.1890947","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1890947"}}